tb-500 and bpc-157 nasal spray Bond Peptides + bpc 157 nasal spray for

In the ATTAIN-2 trial (participants with obesity and type 2 diabetes), GI adverse event rates were somewhat higher than in ATTAIN-1: nausea 20.1-36.4% versus 8.4% with placebo, vomiting 12.8-23.1% versus 3.8%, diarrhea 21.3-27.4% versus 15.0%, and constipation 17.7-22.4% versus 7.8%

Cytokine activity stabilizes, which lowers irritation in the gut (gastritis, intestinal inflammation)

If you have elevated B12 and symptoms like fatigue, weight loss, or abdominal pain, the symptoms are likely from the underlying cause of the elevation , not from the B12 itself

Koppe T, Patchen B, Cheng A, Bhasin M, Vulpe C, Schwartz RE, Moreno-navarrete JM, Fernandez-real JM, Pissios P, Fraenkel PG (2017) Nicotinamide N -methyltransferase expression decreases in iron overload, exacerbating toxicity in mouse hepatocytes

Mild soreness or redness at the site is normal

They increase their dose, experience a brief resurgence of appetite suppression, then plateau again